Jennison Associates
GILD icon

Jennison Associates’s Gilead Sciences GILD Stock Holding History

Jennison Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-365,000
Closed -$27.4M – 754
2013
Q4 		$27.4M Hold
365,000
– – 0.03% 412
2013
Q3 		$22.9M Buy
365,000
+345,000
+1,725% +$20.6M 0.02% 423
2013
Q2 		$1.02M Buy
+20,000
New +$1.04M ﹤0.01% 589

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates's GILD Position: Q1 2026 in Review

Jennison Associates increased its Gilead Sciences (GILD) stake by 42% in Q1 2026, buying an estimated $52.6M and bringing the position to 1,264,546 shares worth $176M. The position accounts for 0.12% of the portfolio, ranked #83.

Jennison Associates first reported a position in GILD in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.52B in Q3 2013. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Jennison Associates held 1,264,546 shares of Gilead Sciences worth $176M as of Q1 2026.
  • Jennison Associates bought 375,359 Gilead Sciences shares in Q1 2026, an estimated $52.6M.
  • Gilead Sciences made up 0.12% of Jennison Associates's portfolio in Q1 2026, its #83 holding.
  • Jennison Associates first reported a position in Gilead Sciences in Q2 2013 and has held it in 23 quarters since.
  • Jennison Associates's Gilead Sciences position peaked at $1.52B in Q3 2013.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.